| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Molecular Epidemiology Laboratory, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York
The incidence of melanoma is increasing rapidly in western
countries. Genetic predisposition in familial and in some sporadic
melanomas has been associated with the presence of
INK4A gene mutations. To better define the risk for
developing sporadic melanoma based on genetic and environmental
interactions, large groups of cases need to be studied.
Mutational analysis of genes lacking hot spots for sequence variations
is time consuming and expensive. In this study we present the
application of denaturing high performance liquid chromatography
(DHPLC) for screening of mutations. Exons 1
, 2, and
3 were amplified from 129 samples and 13 known mutants,
yielding 347 products that were examined at different
temperatures. Forty-two of these amplicons showed a distinct
non-wild-type profile on the chromatogram. Independent sequencing
analysis confirmed 16 different nucleotide variations in
Leu32Pro; Ile49Thr; 88 del G; Gln50Arg; Arg24Pro; Met53Ile;
Met53Thr; Arg58stop; Pro81Leu; Asp84Ala; Arg80stop; Gly101Trp;
Val106Val; Ala148Thr; and in positions (-2) in intron 1 (C
T); and
in the 3' UTR, nucleotide 500 (C
G). No false negatives or
false positives were obtained by DHPLC in samples with mutations or
polymorphisms. We conclude that the DHPLC is a fast,
sensitive, cost-efficient, and reliable method for the
scanning of INK4A somatic or germline mutations and
polymorphisms of large number of samples.
This article has been cited by other articles:
![]() |
M. Berwick, I. Orlow, A. J. Hummer, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. Anton-Culver, R. Zanetti, et al. The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1520 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Begg, I. Orlow, A. J. Hummer, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. Anton-Culver, R. Zanetti, et al. Lifetime Risk of Melanoma in CDKN2A Mutation Carriers in a Population-Based Sample J Natl Cancer Inst, October 19, 2005; 97(20): 1507 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ahsan and A. G. Rundle Measures of genotype versus gene products: promise and pitfalls in cancer prevention Carcinogenesis, September 1, 2003; 24(9): 1429 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Bodamer, D. Bercovich, M. Schlabach, C. Ballantyne, D. Zoch, and A. L. Beaudet Use of Denaturing HPLC to Provide Efficient Detection of Mutations Causing Familial Hypercholesterolemia Clin. Chem., November 1, 2002; 48(11): 1913 - 1918. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |